See the DrugPatentWatch profile for cosentyx

There is currently limited information available on the direct impact of Cosentyx (secukinumab) on vaccine response at injection sites. However, it is known that Cosentyx is a biologic medication used to treat various inflammatory diseases, such as psoriasis, psoriatic arthritis, and ankylosing spondylitis [1].

Biologic medications, like Cosentyx, work by targeting specific proteins in the immune system [1]. This action may have implications for vaccine effectiveness, as vaccines rely on the immune system's response to generate protection against certain diseases [2].

A study published in the Journal of the American Academy of Dermatology investigated the impact of biologic therapies, including secukinumab (Cosentyx), on vaccine-induced immune responses [3]. The study found that patients receiving biologic therapies, including secukinumab, may have a reduced response to vaccines compared to those not on these medications [3]. However, the study did not specifically focus on the impact of Cosentyx on vaccine response at injection sites.

It is important to note that the Centers for Disease Control and Prevention (CDC) recommends that individuals on biologic therapies, like Cosentyx, stay up-to-date with recommended vaccinations [4]. However, the CDC advises that some live vaccines should be administered at specific intervals before or after biologic therapy initiation to ensure an adequate immune response [4].

In summary, there is limited information on the direct impact of Cosentyx on vaccine response at injection sites. While biologic therapies, including Cosentyx, may affect vaccine-induced immune responses, it is essential for individuals on these medications to stay up-to-date with recommended vaccinations [1][3][4].

Sources:
[1] DrugPatentWatch.com - Cosentyx (secukinumab)
https://www.drugpatentwatch.com/drugs/cosentyx
[2] Centers for Disease Control and Prevention - Vaccine Basics
https://www.cdc.gov/vaccines/vac-basics/index.html
[3] Journal of the American Academy of Dermatology - Impact of biologic therapies on vaccine-induced immune responses in patients with immune-mediated inflammatory diseases
https://www.jaad.org/article/S0190-9622(18)31532-3/fulltext
[4] Centers for Disease Control and Prevention - Recommended Immunization Schedules for Persons Aged 0 Through 18 Years
https://www.cdc.gov/vaccines/schedules/hcp/imz/child-adolescent.html